BACKGROUND: Breast cancer is the most common cancer diagnosed among Latinas in the United States and the leading cause of cancer-related death among this population. Latinas tend to be diagnosed at a later stage and have worse prognostic features than their non-Hispanic white counterparts. Genetic and genomic factors may contribute to observed breast cancer health disparities in Latinas. METHODS: We provide a landscape of our current understanding and the existing gaps that need to be filled across the cancer prevention and control continuum. RESULTS: We summarize available data on mutations in high and moderate penetrance genes for inherited risk of breast cancer and the associated literature on disparities in awareness of and uptake of genetic counseling and testing in Latina populations. We also discuss common genetic polymorphisms and risk of breast cancer in Latinas. In the treatment setting, we examine tumor genomics and pharmacogenomics in Latina patients with breast cancer. CONCLUSIONS: As the US population continues to diversify, extending genetic and genomic research into this underserved and understudied population is critical. By understanding the risk of breast cancer among ethnically diverse populations, we will be better positioned to make treatment advancements for earlier stages of cancer, identify more effective and ideally less toxic treatment regimens, and increase rates of survival.
BACKGROUND:Breast cancer is the most common cancer diagnosed among Latinas in the United States and the leading cause of cancer-related death among this population. Latinas tend to be diagnosed at a later stage and have worse prognostic features than their non-Hispanic white counterparts. Genetic and genomic factors may contribute to observed breast cancer health disparities in Latinas. METHODS: We provide a landscape of our current understanding and the existing gaps that need to be filled across the cancer prevention and control continuum. RESULTS: We summarize available data on mutations in high and moderate penetrance genes for inherited risk of breast cancer and the associated literature on disparities in awareness of and uptake of genetic counseling and testing in Latina populations. We also discuss common genetic polymorphisms and risk of breast cancer in Latinas. In the treatment setting, we examine tumor genomics and pharmacogenomics in Latina patients with breast cancer. CONCLUSIONS: As the US population continues to diversify, extending genetic and genomic research into this underserved and understudied population is critical. By understanding the risk of breast cancer among ethnically diverse populations, we will be better positioned to make treatment advancements for earlier stages of cancer, identify more effective and ideally less toxic treatment regimens, and increase rates of survival.
Authors: Bert Gold; Tomas Kirchhoff; Stefan Stefanov; James Lautenberger; Agnes Viale; Judy Garber; Eitan Friedman; Steven Narod; Adam B Olshen; Peter Gregersen; Kristi Kosarin; Adam Olsh; Julie Bergeron; Nathan A Ellis; Robert J Klein; Andrew G Clark; Larry Norton; Michael Dean; Jeff Boyd; Kenneth Offit Journal: Proc Natl Acad Sci U S A Date: 2008-03-07 Impact factor: 11.205
Authors: Miguel de la Hoya; Ana Osorio; Javier Godino; Sara Sulleiro; Alicia Tosar; Pedro Perez-Segura; Cristina Fernandez; Raquel Rodríguez; Eduardo Díaz-Rubio; Javier Benítez; Peter Devilee; Trinidad Caldés Journal: Int J Cancer Date: 2002-02-01 Impact factor: 7.396
Authors: Jeffrey N Weitzel; Jessica Clague; Arelis Martir-Negron; Raquel Ogaz; Josef Herzog; Charité Ricker; Chelsy Jungbluth; Cheryl Cina; Paul Duncan; Gary Unzeitig; J Salvador Saldivar; Mary Beattie; Nancy Feldman; Sharon Sand; Danielle Port; Deborah I Barragan; Esther M John; Susan L Neuhausen; Garrett P Larson Journal: J Clin Oncol Date: 2012-12-10 Impact factor: 44.544
Authors: Magali Olivier; David E Goldgar; Nayanta Sodha; Hiroko Ohgaki; Paul Kleihues; Pierre Hainaut; Rosalind A Eeles Journal: Cancer Res Date: 2003-10-15 Impact factor: 12.701
Authors: Juliana Giacomazzi; Marcia S Graudenz; Cynthia A B T Osorio; Patricia Koehler-Santos; Edenir I Palmero; Marcelo Zagonel-Oliveira; Rodrigo A D Michelli; Cristovam Scapulatempo Neto; Gabriela C Fernandes; Maria Isabel W S Achatz; Ghyslaine Martel-Planche; Fernando A Soares; Maira Caleffi; José Roberto Goldim; Pierre Hainaut; Suzi A Camey; Patricia Ashton-Prolla Journal: PLoS One Date: 2014-06-17 Impact factor: 3.240
Authors: Gina Merchant; Christina Buelna; Sheila F Castañeda; Elva M Arredondo; Simon J Marshall; Garrett Strizich; Daniela Sotres-Alvarez; Earle C Chambers; Robert G McMurray; Kelly R Evenson; Mark Stoutenberg; Arlene L Hankinson; Gregory A Talavera Journal: Prev Med Rep Date: 2015-10-22
Authors: Belinda Vicuña; Harold D Delaney; Kristina G Flores; Lori Ballinger; Melanie Royce; Zoneddy Dayao; Tuya Pal; Anita Y Kinney Journal: J Community Genet Date: 2017-10-02
Authors: Claire C Conley; Eida M Castro-Figueroa; Laura Moreno; Julie Dutil; Jennifer D García; Carolina Burgos; Charité Ricker; Jongphil Kim; Kristi D Graves; Kimlin Tam Ashing; Gwendolyn P Quinn; Hatem Soliman; Susan T Vadaparampil Journal: J Genet Couns Date: 2020-09-16 Impact factor: 2.537
Authors: Susan T Vadaparampil; Laura Moreno Botero; Lindsay Fuzzell; Jennifer Garcia; Lina Jandorf; Alejandra Hurtado-de-Mendoza; Claudia Campos-Galvan; Beth N Peshkin; Marc D Schwartz; Katherine Lopez; Charité Ricker; Katie Fiallos; Gwendolyn P Quinn; Kristi D Graves Journal: Transl Behav Med Date: 2022-01-18 Impact factor: 3.626